539 related articles for article (PubMed ID: 16954577)
21. Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients.
Kang S; Yang YJ; Xu B; Chen JL; Qiao SB; Yao M; Chen J; Wu YJ; Liu HB; Dai J; Yuan JQ; Li JJ; Gao RL
Chin Med J (Engl); 2006 Jul; 119(14):1157-64. PubMed ID: 16863606
[TBL] [Abstract][Full Text] [Related]
22. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
23. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
24. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET).
Brunner-La Rocca HP; Kaiser C; Pfisterer M;
Eur Heart J; 2007 Mar; 28(6):719-25. PubMed ID: 17298975
[TBL] [Abstract][Full Text] [Related]
25. Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database.
Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Wang Y; Dou KF; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li W
Chin Med J (Engl); 2009 Oct; 122(19):2261-7. PubMed ID: 20079124
[TBL] [Abstract][Full Text] [Related]
26. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Roy P; Buch AN; Javaid A; Okabe T; Raya V; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Feb; 101(3):293-9. PubMed ID: 18237587
[TBL] [Abstract][Full Text] [Related]
27. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
29. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
Harjai KJ; Sattur S; Orshaw P; Boura J
J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease.
Mishkel GJ; Varghese JJ; Moore AL; Aguirre F; Markwell SJ; Shelton M
J Invasive Cardiol; 2007 Aug; 19(8):331-7. PubMed ID: 17712200
[TBL] [Abstract][Full Text] [Related]
31. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
32. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
Kornowski R; Vaknin-Assa H; Lev E; Ben-Dor I; Teplitsky I; Rechavia E; Brosh D; Fuchs S; Assali A
Acute Card Care; 2008; 10(3):167-72. PubMed ID: 18803074
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
35. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
[TBL] [Abstract][Full Text] [Related]
37. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents.
Hannan EL; Racz M; Holmes DR; Walford G; Sharma S; Katz S; Jones RH; King SB
Circulation; 2008 Apr; 117(16):2071-8. PubMed ID: 18391112
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
39. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
40. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry.
Burzotta F; Sgueglia GA; Trani C; Talarico GP; Coroleu SF; Giubilato S; Niccoli G; Giammarinaro M; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
J Invasive Cardiol; 2009 Oct; 21(10):532-7. PubMed ID: 19805841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]